Myrox®

Ambroxol
Myrox®

Prescribing Details



Description
Myrox ® is a preparation of Ambroxol Hydrochloride. It possesses both expectorant & mucolytic effects. It dilutes the thick mucus in the respiration track and facilitates excretion of it. It also increases bronchial secretion and decreases viscosity to make coughs more productive. Long-term use is possible because of good tolerability of the preparation.

Uses
No Data

Indications
Myrox ® is indicated in
  • Productive cough
  • Acute and chronic inflammatory disorders of upper and lower respiratory tract associated with viscous mucus including acute and chronic bronchitis.
  • Inflammatory diseases of rhino-pharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus.
  • Asthmatic bronchitis, bronchial asthma with thick expectoration.
  • Bronchiectasis
  • Chronic pneumonia

Dosage and administration
Myrox ® SR Capsule:
Adults and children over 12 years old: 1 capsule daily.

Myrox ® Syrup:
Adult: 10ml 3 times daily.
Children 2-6 years: ½ teaspoonful 2 to 3 times daily.
Children 6-12 years: 1 teaspoonful 2 to 3 times daily.

Myrox ® Pediatric Drops:
Children 0-6 months: 0.5ml 2 times daily.
Children 6-12 months: 1ml 2 times daily.
Children 12-24 months: 1.5ml 2 times daily

Use in pregnancy & lactation
Myrox ® (ambroxol) should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnantwomen with ambroxol. Special care is recommended during pregnancy, especially during the first 3 months of pregnancy. It is not known whether ambroxol is secreted in human milk. Because many drugs are excreted in human milk, Myrox ® should not be administered to a breastfeeding woman.

Geriatric use
No Data

Precautions
Caution is necessary when bronchomotoric function is impaired. Patients with hepatic and renal insufficiency should take it with caution. Ambroxol should not be given with cough suppressants, as a dangerous increase of bronchial secretion occur. Ambroxol should be given with care to patients suffering from peptic ulcer.

Side effects
Headache, nausea, gastrointestinal troubles are only seldom reported.

Contraindications
Contraindicated in ascertained hypersensitivity to Ambroxol.

Drug interactions
Ambroxol has no interaction with cardioactive glycosides, corticosteroids, bronchodilators, diuretics and antibiotics normally used in the treatment of bronchopulmonary infections.

Overdose
No Data

Preparation
No Data

Pharmaceutical precautions
Store in a cool, dry place. Protect from light.

Presentation
Myrox ® SR Capsule: Opaque purple body and natural transparent cap, both body & cap is imprinted with 'ACI'. Each capsule contains Ambroxol Hydrochloride BP 75mg.
Myrox ® Syrup: A clear pink colored, strawberry flavored syrup. Each 5ml contains Ambroxol Hydrochloride BP 15mg.
Myrox ® Pediatric Drops: A clear pink colored, strawberry flavored. Each 5ml contains Ambroxol Hydrochloride BP 15mg.

Package quantities
Myrox ® SR Capsule: Cartons of 30 capsules in Alu-Alu blister.
Myrox ® Syrup: Bottle of 100ml
Myrox ® Pediatric Drops: Bottle of 15ml.